rss
J Med Ethics 2002;28:277 doi:10.1136/jme.28.4.277-a
  • Letter

Comment on: the influence of the pharmaceutical industry on the off-label use of its medicines

  1. A Herxheimer
  1. UK Cochrane Centre, 9 Park Crescent, London N3 2NL, UK; andrew_herxheimer@compuserve.com

      Gebhardt draws attention to an important issue. The responsibility for informing and warning patients about adverse effects and how to prevent them, or …

      [Full text of this article]

      This Article

      1. Extract
      2. Full text
      3. PDF

      Responses

      1. Submit a response
      2. No responses published

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.